Printer Friendly
The Free Library
19,595,263 articles and books
Member login
User name  
Password 
 
Join us Forgot password?

COR Therapeutics, Inc. Announces Proposed $175 Million Convertible Senior Notes Offering.


Business Editors & Health/Medical Writers

SOUTH SAN FRANCISCO South San Francisco, city (1990 pop. 54,312), San Mateo co., W Calif.; inc. 1908. South San Francisco has several industrial parks; its manufactures include medical supplies and equipment, foods, paint, paper products, consumer goods, and clothing. , Calif.--(BW HealthWire)--June 4, 2001

COR Therapeutics, Inc. (Nasdaq:CORR CORR

Used on the consolidated tape to indicate a correction in a reported transaction : CORR.LAST.GY 50 WAS 51.
) announced today that it proposes to offer a new issue of $175 million of Convertible Senior Notes due 2006 (the "Notes").

The Notes will be convertible into COR Therapeutics Common Stock, at the option of the holder, at a price to be determined. The Company may also issue up to an additional $50 million of Notes to cover over-allotments in connection with the offering.

COR Therapeutics intends to use the proceeds of the sale for research and development activities, possible acquisitions of complementary businesses and technologies, and general corporate purposes.

The Notes have not been registered under the Securities Act of 1933, as amended, or applicable state securities laws, and unless so registered, may not be offered or sold in the United States United States, officially United States of America, republic (2005 est. pop. 295,734,000), 3,539,227 sq mi (9,166,598 sq km), North America. The United States is the world's third largest country in population and the fourth largest country in area. , except pursuant to an applicable exemption from the registration requirements of the Securities Act of 1933, as amended, and applicable state securities laws.

This press release shall not constitute an offer to sell or the solicitation solicitation

In criminal law, the act of asking, inducing, or directing someone to commit a crime. The person soliciting another becomes an accomplice to the crime. The term also refers to the act of obtaining bribes, as well as to the crime of a prostitute who offers sexual
 of an offer to buy the Notes. This press release is being issued pursuant to and in accordance with Rule 135c under the Securities Act of 1933, as amended.

In addition to the historical information contained herein, this press release contains forward-looking statements forward-looking statement

A projected financial statement based on management expectations. A forward-looking statement involves risks with regard to the accuracy of assumptions underlying the projections.
 that involve risks and uncertainties. Actual results may differ materially from the anticipated results discussed in such forward-looking statements, due to factors discussed in the Company's SEC reports, including, but not limited to, the Company's Report on Form 10-Q Form 10-Q

See 10-Q.
 for the quarter ended March 31, 2001, and Report on Form 10-K Form 10-K

A report required by the SEC from exchange-listed companies that provides for annual disclosure of certain financial information.


Form 10-K

See 10-K.
 for the year ended December 31, 2000. Forward-looking statements are based on current expectations and the Company does not intend to update such information to reflect later events or developments.
COPYRIGHT 2001 Business Wire
No portion of this article can be reproduced without the express written permission from the copyright holder.
Copyright 2001, Gale Group. All rights reserved. Gale Group is a Thomson Corporation Company.

 Reader Opinion

Title:

Comment:



 

Article Details
Printer friendly Cite/link Email Feedback
Publication:Business Wire
Geographic Code:1USA
Date:Jun 4, 2001
Words:302
Previous Article:Persistence PowerTier Achieves Java Compatible Enterprise Edition Certification Standard.
Next Article:Infineon Launches SOCRATES 4 the Industry's Lowest Power Multi-Channel SHDSL Transceiver for High Density Line Cards.
Topics:



Related Articles
COR Therapeutics, Inc. Announces Proposed $100 Million Convertible Subordinated Note Offer.
COR Therapeutics, Inc. Raises $250 Million in Convertible Subordinated Debt Placement.
COR Therapeutics, Inc. Announces Private Offering of Convertible Senior Notes.
COR Therapeutics, Inc. Announces the Sale of Additional $50 Million of Notes.
[0] COR Therapeutics, Inc. Announces the Sale of Additional $50 Million of Notes.
COR Therapeutics, Inc. Reports Profitable Second Quarter Driven by 60 Percent Year-Over-Year INTEGRILIN Sales Growth.
Equity returns with fixed-income risk.
COR Therapeutics, Inc. Reports Profitable Third Quarter.
Strong Sales of INTEGRILIN - Eptifibatide - Injection Account for Profitable Fourth Quarter and Year End 2001 for COR Therapeutics, Inc.
Convertibles make the difference: Tracy Maitland's convertible securities strategy lessened market risk. (Stock Update).

Terms of use | Copyright © 2012 Farlex, Inc. | Feedback | For webmasters | Submit articles